Guidelines for the use of platelet transfusions

Guidelines for the use of platelet transfusions

The demand for platelets in England was stable at around 220,000 adult therapeutic doses (ATD) per year until 2007/8 at which point demand has increased year on year to 275,000 ATD in 2014/15, an increase of 25%. Similar rises in demand have been seen in Australia and the United States. A recent rev...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs:	Estcourt, L, Birchall, J, Allard, S, Bassey, S, Hersey, P, Kerr, J, Mumford, A, Stanworth, S, Tinegate, H
Formaat:	Journal article
Gepubliceerd in:	Wiley 2016

Gelijkaardige items

Prophylactic platelet transfusions
door: Estcourt, L, et al.
Gepubliceerd in: (2010)

Alternatives to allogeneic platelet transfusion
door: Desborough, M, et al.
Gepubliceerd in: (2016)

An update on indications for platelet transfusion
door: Wood, E, et al.
Gepubliceerd in: (2016)

Platelet transfusions for patients with haematological malignancies: who needs them?
door: Estcourt, L, et al.
Gepubliceerd in: (2011)

Prophylactic platelet transfusions prior to surgery for people with a low platelet count
door: Estcourt, L, et al.
Gepubliceerd in: (2017)

Prophylactic platelet transfusions prior to surgery for people with a low platelet count
door: Estcourt, L, et al.
Gepubliceerd in: (2018)

Platelet transfusions in haematology patients: are we using them appropriately?
door: Estcourt, L, et al.
Gepubliceerd in: (2012)

Different platelet count thresholds to guide use of prophylactic platelet transfusions for patients with hematological disorders after myelosuppressive chemotherapy or stem cell transplantation
door: Estcourt, L, et al.
Gepubliceerd in: (2016)

Results of a National Survey of Platelet Transfusion Practice
door: Estcourt, L, et al.
Gepubliceerd in: (2011)

Analysis of Current Patterns of Utilisation of Platelet Transfusion Components in Hematology Patients
door: Estcourt, L, et al.
Gepubliceerd in: (2011)

Risk of bleeding and use of platelet transfusions in patients with hematological malignancies: recurrent event analysis
door: Stanworth, S, et al.
Gepubliceerd in: (2015)

Alternatives to prophylactic platelet transfusions
door: Estcourt, L
Gepubliceerd in: (2016)

Platelet transfusions in patients with hypoproliferative thrombocytopenia: conclusions from clinical trials and current controversies
door: Crighton, G, et al.
Gepubliceerd in: (2016)

Use of platelet transfusions prior to lumbar punctures or epidural anaesthesia for the prevention of complications in people with thrombocytopenia
door: Estcourt, L, et al.
Gepubliceerd in: (2016)

Risk of bleeding and use of platelet transfusions in patients with hematologic malignancies: recurrent event analysis
door: Simon J. Stanworth, et al.
Gepubliceerd in: (2015-06-01)

Comparison of different platelet transfusion thresholds prior to insertion of central lines in patients with thrombocytopenia
door: Estcourt, L, et al.
Gepubliceerd in: (2015)

The challenges of measuring bleeding outcomes in clinical trials of platelet transfusions.
door: Estcourt, L, et al.
Gepubliceerd in: (2013)

The challenges of measuring bleeding outcomes in clinical trials of platelet transfusions
door: Estcourt, L, et al.
Gepubliceerd in: (2013)

The challenges of measuring bleeding outcomes in clinical trials of platelet transfusions
door: Estcourt, L, et al.
Gepubliceerd in: (2013)

Use of platelet transfusions prior to lumbar punctures or epidural anaesthesia for the prevention of complications in people with thrombocytopenia (Protocol)
door: Estcourt, L, et al.
Gepubliceerd in: (2015)

Comparison of different platelet transfusion thresholds prior to insertion of central lines in patients with thrombocytopenia (Protocol)
door: Estcourt, L, et al.
Gepubliceerd in: (2015)

Prophylactic platelet transfusions in patients with blood malignancies: Cost analysis of a randomized trial
door: Campbell, H, et al.
Gepubliceerd in: (2014)

Prophylactic platelet transfusions in patients with blood malignancies: cost analysis of a randomized trial.
door: Campbell, H, et al.
Gepubliceerd in: (2014)

Impact of prophylactic platelet transfusions on bleeding events in patients with hematologic malignancies: a subgroup analysis of a randomized trial.
door: Stanworth, S, et al.
Gepubliceerd in: (2014)

Prophylactic platelet transfusion for prevention of bleeding in patients with haematological disorders after chemotherapy and stem cell transplantation.
door: Estcourt, L, et al.
Gepubliceerd in: (2012)

Impact of prophylactic platelet transfusions on bleeding events in patients with hematologic malignancies: A subgroup analysis of a randomized trial (CME)
door: Stanworth, S, et al.
Gepubliceerd in: (2014)

A no-prophylaxis platelet-transfusion strategy for hematologic cancers.
door: Stanworth, S, et al.
Gepubliceerd in: (2013)

Alternatives, and adjuncts, to prophylactic platelet transfusion for people with haematological malignancies undergoing intensive chemotherapy or stem cell transplantation
door: Desborough, M, et al.
Gepubliceerd in: (2016)

Comparison of different platelet count thresholds to guide administration of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation (Review)
door: Estcourt, L, et al.
Gepubliceerd in: (2015)

Different doses of prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation
door: Estcourt, L, et al.
Gepubliceerd in: (2014)

Different doses of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation
door: Estcourt, L, et al.
Gepubliceerd in: (2015)

Prophylactic platelet transfusions in patients with haematological malignancies – lessons from the TOPPS trial
door: Estcourt, L
Gepubliceerd in: (2016)

Platelet transfusion thresholds in premature neonates (PlaNeT-2 trial)
door: Estcourt, LJ
Gepubliceerd in: (2019)

Prophylactic platelet transfusions in critical care – how low can you go?
door: Shah, A, et al.
Gepubliceerd in: (2023)

Alternative agents versus prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation (Protocol).
door: Estcourt, L, et al.
Gepubliceerd in: (2014)

Alternative agents versus prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation (protocol)
door: Estcourt, L, et al.
Gepubliceerd in: (2014)

Prospective observational cohort study of the association between thromboelastometry, coagulation and platelet parameters and bleeding in patients with haematological malignancies- The ATHENA study
door: Estcourt, L, et al.
Gepubliceerd in: (2014)

A therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation
door: Crighton, GL, et al.
Gepubliceerd in: (2015)

Neonatal Thrombocytopenia: Diagnostic Approach and Platelet Transfusion Guideline
door: Ji Sook Kim, et al.
Gepubliceerd in: (2019-10-01)

Universal irradiation of platelets: does irradiation affect the quality, effectiveness, and safety of platelets for transfusion?
door: Cain, L, et al.
Gepubliceerd in: (2024)